( )
A two-component co-formulation of Cagrilintide and a GLP-1class peptide supplied for controlled research environments
may be used until expiration date if kept in the refrigerator If stored at room temperature up to 30C (86F), throw away after 30 days After opening (in-use) Store in the original carton in the refrigerator at 2C to 8C (36F to 46F) or at room temperature up to 30C (86F) Throw away after a total of 30 days at room temperature, 30 days after first use, or after taking 4 weekly doses (whichever occurs first), even if there is medicine left in it LONG-TERM SAFETY Zepbound was FDA-approved in 2023
L-carnitine transports fatty acids into the mitochondria for energy production, forming the basis for its use in metabolic and body-contouring programmes
Retatrutide, CagriSema and Emerging Treatments Retatrutide, CagriSema, survodutide, MariTide, VK2735, eloralintide and other next-generation treatments remain investigational for routine obesity care as of July 2026
